Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Long-Term Investments (2016 - 2018)

Edesa Biotech's Long-Term Investments history spans 3 years, with the latest figure at $46456.0 for Q3 2018.

  • For Q3 2018, Long-Term Investments fell 30.35% year-over-year to $46456.0; the TTM value through Sep 2018 reached $46456.0, down 30.35%, while the annual FY2018 figure was $46456.0, 30.35% down from the prior year.
  • Long-Term Investments for Q3 2018 was $46456.0 at Edesa Biotech, down from $66695.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $67000.0 in Q3 2016 and bottomed at $46456.0 in Q3 2018.
  • The 3-year median for Long-Term Investments is $66695.0 (2016), against an average of $64701.6.
  • The largest annual shift saw Long-Term Investments changed 0.0% in 2017 before it tumbled 30.35% in 2018.
  • A 3-year view of Long-Term Investments shows it stood at $66695.0 in 2016, then changed by 0.0% to $66695.0 in 2017, then plummeted by 30.35% to $46456.0 in 2018.
  • Per Business Quant, the three most recent readings for EDSA's Long-Term Investments are $46456.0 (Q3 2018), $66695.0 (Q2 2018), and $66695.0 (Q1 2018).